Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
1FG0:FRA
Kyntra Bio Inc
€5.80
0.00%
(0.00) 1D
Apr 28, 8:02:40 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1FG0...
Open
€5.80
High
€5.80
Low
€5.80
Mkt. cap
28.45M
Avg. vol.
0.00
Volume
0.00
52-wk high
€10.10
52-wk low
€5.35
No. of employees
34
News stories
From sources across the web
Profile
Kyntra Bio, Inc. is a biopharmaceutical company headquartered in San Francisco, California. Once regarded as a promising developer of innovative therapies for anemia and fibrotic diseases, with a market capitalization of roughly $4 billion in 2018–19, the company's value collapsed following late-stage trial failures, regulatory setbacks, and a data manipulation scandal. By 2026, Kyntra was mainly reduced to a single early-stage oncology drug candidate. On January 8, 2026, FibroGen changed its name to Kyntra Bio and ticker symbol to KYNB. Wikipedia
About Kyntra Bio Inc
CEO-
Employees34
FoundedJan 1, 1993
HeadquartersSan Francisco, California, United States
SectorBiotechnology
Websitefibrogen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.74M
1.35M
1.08M
1.28M
Cost of goods sold
9.43M
5.95M
1.15M
7.55M
Cost of revenue
9.43M
5.95M
1.15M
7.55M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.11M
7.06M
5.30M
7.25M
Operating expense
8.11M
7.06M
5.30M
7.25M
Total operating expenses
17.53M
13.01M
6.45M
14.80M
Operating income
-14.79M
-11.66M
-5.37M
-13.52M
Other non operating income
-
-
-
-
EBT including unusual items
-16.76M
-13.78M
-13.15M
-14.61M
EBT excluding unusual items
-16.64M
-13.38M
-6.52M
-14.62M
Income tax expense
2.00K
-92.00K
-
-
Effective tax rate
-0.01%
0.67%
-
-
Other operating expenses
-
-
-
-
Net income
4.64M
-7.60M
200.64M
-14.22M
Net profit margin
169.37%
-564.02%
18,646.47%
-1,113.55%
Earnings per share
1.25
-1.88
49.61
-3.51
Interest and investment income
413.00K
286.00K
931.00K
1.32M
Interest expense
-2.26M
-2.01M
-2.08M
-2.41M
Net interest expenses
-1.84M
-1.72M
-1.15M
-1.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.47M
-11.44M
-5.18M
-13.51M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer